Loading, Please Wait...
SALEM, NH--(Marketwired - Mar 15, 2016) - ProPhotonix Limited (
OTC: STKR; AIM: PPIX
PRELIMINARY RESULTS FOR THE YEAR ENDED DECEMBER 31, 2015
Annual General Meeting Date
(Salem, New Hampshire, March 15, 2016) ProPhotonix Limited (
Annual General Meeting
The Company will hold the Annual General Meeting of the Shareholders on May 19, 2016 at 2:00 PM British Summer Time at the offices of K&L Gates LLP, One New Change, London EC4M 9AF. The Record date is set at March 24, 2016 for all shareholders of record.
Tim Losik, President & CEO, Commented:
"We entered 2015 with positive financial momentum from the prior year, but also with economic and foreign currency exchange rate headwinds. Neither of these challenges abated during the year making continuing financial success all the more meaningful. 2015 has again been a year of accomplishments in a number of respects - including our first full year of positive net income since 1994. We have now also achieved five consecutive half-yearly periods of positive EBITDA and three consecutive half-yearly periods of positive operating income. During 2015, operating income increased sevenfold and EBITDA increased 84%. In addition, the ProPhotonix team has been diligently pursuing new customers and new product and market initiatives, which helps set the stage for 2016."
Full Year 2015 Financial Results
Revenue fell by 12% during 2015, the year over year comparatives are significantly impacted by foreign currency conversion rates. While revenue for 2015 was $14.4 million, this would have been $15.8 million using constant currency exchange rates from 2014. Our margin rate improved to 41.4% resulting from a better product mix and continuing cost reductions. Operating expenses, excluding intangible amortization charges, totalled $5.2 million (2014: $6.2 million). Approximately 39% of the expense improvement was due to the impact of foreign currency fluctuations. Sales and marketing expenses were down 25% compared to last year at $1.8 million, while general and administrative and research and development expenses were reduced by approximately $0.4 million, or 12% over 2014. The Company achieved an operating profit of $0.8 million and EBITDA of $1.2 million. These factors contributed to ProPhotonix's financial improvement and positive net income of $0.3 million (2014: net loss $1.3 million). The balance sheet also continued to improve in 2015. Term debt declined $750,000 to $1,474,000 as at 31 December 2015, which is the lowest outstanding balance in more than a decade.
During 2015, order bookings declined 2.4% to $15.7 million from 2014, but the book-to-bill ratio increased to 1.09 (2014: 0.98). However, factoring in the impact of constant currency exchange rates from 2014, our order rate for 2015 would have been $17.3 million (a 7.6% improvement). Our backlog at December 31, 2015 was $5.6 million (2014: $5.6 million).
Customer and Product Development Initiatives:
In addition to the new customer activity in 2015, we entered into three (3) three-year supply agreements with customers and have received and fulfilled production orders for two of the three agreements beginning in Q4, 2015. We will begin commercial shipments on the third agreement in Q1 2016.
During the year, the ProPhotonix engineering team completed the development of several products and implemented a number of new technology capabilities. Furthermore, we announced eight new manufactured products. The Company filed four provisional/patent applications in 2015 as a continuation of intellectual property protection on our unique inventions and solutions.
Building toward the future:
Strategically, the Company is in transition. Our product development has historically been customer directed. This approach has served us well for specific applications and we continue to offer bespoke product solutions. However, we are now assessing various markets and product features in order to develop a product strategy focusing on specific markets to complement our direct customer engagement. We have identified two promising opportunities and we are concentrating our engineering talents in defined market areas that we believe are poised for fast market expansion.
The first of these is the UV LED and laser market for various applications including: printing, curing, 3D printing, bio-luminescence, medical microscopy, and other applications. Market research shows that the 2014 market size for UV LED applications was approximately $90 million with projected growth to $500 million by 2019, a compound average annual growth rate of nearly 40%. We have announced new products addressing this rapidly growing market and will continue with further product development.
Our other focus is on the continuing market requirement for multi-wavelength devices and systems; both laser and LED solutions. Increasingly, customers are seeking multi-wavelength solutions requiring innovative optics, complex electronics, on-board sensing capabilities, and sophisticated software control. We see opportunities which include a broad range of applications in microscopy, industrial, embedded camera and sensor calibration, solar simulators, optical sorting, and security markets. We are in the research and development phase of these products and expect to announce various laser and LED products in the future.
Strategy and Markets
ProPhotonix consists of two business units: an LED systems manufacturing business based in Ireland (Cork), and a laser modules production and laser diode distribution business located in the United Kingdom (Hatfield Broad Oak). Corporate headquarters and the North American sales activities are based in Salem, New Hampshire, USA. The fundamental strategy of the Company is growth in revenue through its existing customers, new customer activity, and new product and market expansion. ProPhotonix's short-term strategy has been to reach sustained positive EBITDA, cash flow, and net income. These continuing goals will be accomplished through a relentless focus on cost management and most importantly through revenue growth.
ProPhotonix's growth in the medium-term will be accomplished with new customer wins and the conversion of development orders into long run production orders. Prophotonix is also focused on expansion into new markets and new products. The Company continuously evaluates new product development and additions to the sales offering in an effort to increase customer satisfaction and provide solutions.
ProPhotonix sells its products principally into three markets: industrial (primarily machine vision illumination), medical, and homeland security and defense. The Company foresees growth opportunities in all three markets it serves which are briefly described below:
Industrial (Machine Vision)
Within the industrial market, machine vision is the term used to describe computerized analysis for controlling manufacturing processes, for example automated inspection. In terms of quality and speed, lighting is often a critical component in machine vision and the Company manufactures both LED systems and lasers designed specifically for this market. The recently enhanced 3D Pro Laser line generators and improved LED line light family specifically address this market.
The Company has experienced successes in the medical (including dental) market and has gained a foothold in the sector, supplying a variety of applications with current customers, including the world leader in stationary imaging equipment, a portable x-ray equipment manufacturer, a dental imaging manufacturer and also a pioneer in the manufacturing of devices offering eye tracking capability utilizing ProPhotonix's custom infrared LED arrays. The Company intends to broaden its product marketing effort in the medical field since it offers significant long-term revenue growth opportunities.
Homeland Security & Defense
LED systems, laser modules and laser diodes are used in a wide variety of applications in the security and defense fields. The Company currently supplies several defense sighting manufacturers in the US and Europe, as well as leading manufacturers of Auto Number Plate Recognition systems. This market offers significant growth opportunities for ProPhotonix over the next several years and the Company is currently marketing its laser and LED capabilities to additional security and optical character recognition systems companies in this market space.
ProPhotonix begins 2016 in a strong position, having received production orders from the three customers who have signed three year supply agreements during 2015. We have also progressed our UV product family to include the COBRA Cure FX1, an innovative UV LED Curing system, which we recently announced. Recent booking trends, the macroeconomic environment and foreign exchange rate impacts cause us to be cautious for the first half of 2016, but we remain very positive about our business pipeline and confident in our ability to achieve continued positive momentum toward our profitability objectives.
Tim Losik, President and CEO
|Tel: +1 603 893 8778
|Stockdale Securities Limited
Tom Griffiths and David Coaten
|Tel: +44 (0) 20 7601 6100|
|Nominated Adviser and Broker|
Click on, or paste the following link into your web browser, to view the associated PDF document.
ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio (formerly Oclaro), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com
This information is provided by RNS
The company news service from the London Stock Exchange